Crosslinkable fluorophenoxy‐substituted poly[bis(octafluoropentoxy) phosphazene] biomaterials with improved antimicrobial effect and hemocompatibility
Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2023
DOI: 10.1002/jbm.b.35252 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2023. Verfasst von Shelby Alwine und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biomolecular Science, Clarkson University, Potsdam, New York, 13699, USA. Hauptthemen laut MEDLINE: Biocompatible Materials, Anti-Infective Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NIAID NIH HHS, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Biomaterial‐associated microbial infection is one of the most frequent and severe complications associated with the use of biomaterials in medical devices. In previous studies, we developed new fluorinated polyphosphazenes, poly[bis(octafluoropentoxy) phosphazene] (OFP) and crosslinkable OFP (X‐OFP), and demonstrated the inhibition of bacterial adhesion and biofilm formation, thereby controlling microbial infection. In this study, two additional fluorinated polyphosphazenes (PPs, defined as LS02 and LS03) with fluorophenoxy‐substituted side groups, 4‐fluorophenoxy and 4‐(trifluoromethyl)phenoxy, respectively, based on X‐OFP general structure, were synthesized and applied as coatings on stainless steel. The linkage of fluorophenoxy groups to the P‐N backbone of PPs was found to increase the surface stiffness and significantly reduced Staphylococcus bacterial adhesion and inhibited biofilm formation. It also significantly reduced microbial infection compared to OFP, our prior X‐OFPs or poly[bis(trifluoroethoxy) phosphazene] (TFE). The biofilm experiments show that the newly synthesized PPs LS02 and LS03 are biofilm free up to 28 days. Plasma coagulation and platelet adhesion/activation experiments also demonstrated that new PPs containing fluorophenoxy side groups are hemocompatible. The development of new crosslinkable fluorinated PPs containing fluorophenoxy‐substituted side groups provides a new generation of polyphosphazene materials for medical devices with improved resistance to microbial infections and thrombosis formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biomolecular Science, Clarkson University, Potsdam, New York, 13699, USA.
- Department of Chemistry, The Pennsylvania State University, University Park, Pennsylvania, 16802, USA.
- Department of Surgery, The Pennsylvania State University, College of Medicine, Hershey, Pennsylvania, 17033, USA.
- Department of Biomedical Engineering, The Pennsylvania State University, Hershey, Pennsylvania, 17033, USA.
ORCID-Profile: Christopher A Siedlecki, Li-Chong Xu
Förderung
- NHLBI NIH HHS
- NIAID NIH HHS
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Alwine, S., Chen, C., Shen, L., Allcock, H. R., Siedlecki, C. A., & Xu, L. C. (2023). Crosslinkable fluorophenoxy‐substituted poly[bis(octafluoropentoxy) phosphazene] biomaterials with improved antimicrobial effect and hemocompatibility. Journal of Biomedical Materials Research Part B: Applied Biomaterials. https://doi.org/10.1002/jbm.b.35252
Vancouver
Alwine S, Chen C, Shen L, Allcock HR, Siedlecki CA, Xu LC. Crosslinkable fluorophenoxy‐substituted poly[bis(octafluoropentoxy) phosphazene] biomaterials with improved antimicrobial effect and hemocompatibility. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2023. doi:10.1002/jbm.b.35252
BibTeX
@article{Alwine2023,
author = {Alwine, Shelby and Chen, Chen and Shen, Lihui and Allcock, Harry R and Siedlecki, Christopher A and Xu, Li-Chong},
title = {Crosslinkable fluorophenoxy‐substituted poly[bis(octafluoropentoxy) phosphazene] biomaterials with improved antimicrobial effect and hemocompatibility},
journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
year = {2023},
doi = {10.1002/jbm.b.35252}
}
EUVIMED